Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 17320513646 |
| E-mail: | mike@molcoo.com |
| QQ: | 3001071511 |
| Skype: | Chat Now! |
| Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
|
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
|
| Product Name | MF | CAS | Details |
|---|
| Phe1-Octreotide | Details |
| N-Nitroso Niraparib | Details |
| Mianserin Impurity 12(Hydrochloride) | Details |
| Amlodipine Nitroso Impurity 66 | Details |
| 7-D-Leu-Deslorelin | Details |
| 5-D-Tyr-Deslorelin | Details |
| Glycoyl-Thr-Octreotide | Details |
| (Des-Gly10,D-Pyr1,D-Leu6,Pro-NHEt9)-LHRH;Leuprolide Acetate EP Impurity I | C59H84N16O12 | 1926163-26-9 | Details |
| Estradiol Valerate EP impurity C | C23H30O3 | 95959-20-9 | Details |
| 1,4-Dinitrosopiperazine | C4H8N4O2 | 140-79-4 | Details |
| DPhe 12 Bivalirudin | Details |
| DPhe3-Octreotide | Details |
| Oxytocin impurity 18;Ac-oxytocin;N-Acetyloxytocin;1-(N-acetylcysteine) Oxytocin;Oxytocin EP Impurity E | C45H68N12O13S2 | 10551-48-1 | Details |
| N-nitroso Landiolol | Details |
| Oxytocin Trisulfide | Details |
| Mirabegron Impurity 33 | 3017159-61-1 | Details |
| Carebastine Impurity 7 | C16H22O4 | 2270171-31-6 | Details |
| 9-D-Pro-Deslorelin | Details |
| Glycoglycoyl-Lys-Octreotide | Details |
| Leuprorelin impurity;Des-Pro Leuprorelin | Details |
| Des-Ser4-Alarelin | Details |
| Leuprorelin (Leuprolide) EP Impurity J | Details |
| N-Nitroso Ambroxol | Details |
| Estrone 3-Valerate | C23H30O3 | 128788-26-1 | Details |
| Iloperidone Impurity 27 | C12H13FN2O | 84163-64-4 | Details |
| Bivalirudin Impurity 3;Bivalirudin D-Asn Impurity;DAsn9 Bivalirudin | C98H138N24O33 | 1310025-28-5 | Details |
| Thr9-Octreotide | C51H68N10O11S2 | 1546983-33-8 | Details |
| Octreotide impurity B;DCys7-Octreotide | Details |
| N-Nitroso Benzylpenicillin Impurity 1 | Details |
| Asu9 Bivalirudin | Details |
| DaThr-Octreotide | Details |
| (D-SER4)-GOSERELIN; (D-Ser4,D-Ser(tBu)6,Azagly10)-LHRH | C59H84N18O14 | 1926163-39-4 | Details |
| (+Arg8)-Alarelin;Di-Arg-Alarelin | Details |
| Des-Gly9-Oxytocin | Details |
| Tolmetin Impurity 1 | C16H17NO3 | 2512220-17-4 | Details |
| Di-Thr6-Octreotide; Octreotide Impurity 19 | Details |
| Rivaroxaban Nitroso Impurity | Details |
| DLys-Octreotide | Details |
| N-Nitroso Cyclophosphamide USP Related Compound A | C4H8Cl2N2O | 67856-68-2 | Details |
| linear Octreotide | Details |
| L-Lactolactoyl-Lys-Octreotide | Details |
| Goserelin EP Impurity K; (Ser(Ac)4,D-Ser(tBu)6,Azagly10)-LHRH; | C61H86N18O15 | 1926163-83-8 | Details |
| Leuprorelin EP Impurity C | C59H84N16O12 | 54785-87-4 | Details |
| (+Pro5)-Alarelin | Details |
| Asp9 Bivalirudin | Details |
| Leuprorelin (Leuprolide) EP Impurity K | Details |
| D-Gln4-Oxytocin | Details |
| Tolmetin Impurity 3 | C16H17NO3 | 2514774-72-0 | Details |
| 1-Nitrosopiperazine(Trifluoroacetate) | C4H9N3O | Details |
| 1-11 Bivalirudin; D-Phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartic acid | C43H63N15O15 | 1224964-33-3 | Details |
| Leuprorelin impurity 32 | Details |
| Oia Leuprorelin | Details |
| 6-L-Trp-Deslorelin;L-Trp (6)-Deslorelin;5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-L- tryptophyl -L-leucyl-L-arginyl-N-ethyl-L-prolinamide | Details |
| 2-D-His-Deslorelin | Details |
| Leuprorelin impurity; Des-Ser Leuprorelin | C56H79N15O10 | 267878-61-5 | Details |
| Bivalirudin Impurity 1; (S)-2-(3-amino-2, 5-dioxopyrrolidin-1-yl)acetic acid | C6H8N2O4 | 72378-50-8 | Details |
| Acetyl-Lys-octreotide;Impurity H (EP/BP) | C51H68N10O11S2 | 173606-11-6 | Details |
| Octreotide impurity G;DCys2-Octreotide | C49H66N10O10S2 | 108102-47-2 | Details |
| Baricitinib Impurity 73 | C7H13BN2O3 | Details |
| Oxytocin | C43H65N11O13S2 | 24346-32-5 | Details |
| Goserelin EP Impurity E;Goserelin-(1-8)-peptidyl-L-prolinohydrazide;(Des-Gly10,D-Ser(tBu)6,Pro-NHNH29)-LHRH | C58H83N17O13 | 147688-42-4 | Details |
| Asp5-Oxytocin | C43H65N11O13S2 | 65907-78-0 | Details |
| Baloxavir Impurity 36 | Details |
| Oxy[+Gly10]; [+Gly10]Oxytocin | Details |
| [AC-D-Phe1,D-Cys7]-OCTR;Octreotide Impurity A(EP/BP) | Details |
| D-Ser4 Leuprolide;[4-D-serine]leuprorelin | C59H84N16O12 | 62621-13-0 | Details |
| N-Nitroso Bevantolol | Details |
| Baricitinib Nitroso Impurity 89 | Details |
| Glycoglycoyl-Thr-Octreotide | Details |
| 3-D-Trp-Deslorelin | Details |
| 4-D-Ser-Deslorelin | Details |
| Buserelin EP Impurity B;[4-D-serine]buserelin | C60H86N16O13 | 1926163-21-4 | Details |
| Gonadoliberin A;LHRH (free acid) | C55H74N16O14 | 35263-73-1 | Details |
| N-Nitroso Duloxetine | Details |
| Tolmetin Impurity 2 | C19H22N2O3 | 2514774-68-4 | Details |
| Glu4-Oxytocin | C43H65N11O13S2 | 4314-67-4 | Details |
| Baricitinib Impurity 88 | Details |
| Etonogestrel Impurity 7 | C20H26O2 | 54024-17-8 | Details |
| [4-(O-Acetyl-L-serine)]leuprorelin;O-Acetyl-Ser4 Leuprolide | C61H86N16O13 | 1926163-25-8 | Details |
| alpha-Oxytocin Dimer;Oxytocin parallel dimer;Parallel dimer oxytocin | C86H132N24O24S4 | 19645-28-4 | Details |
| D-His2 Leuprolide | C59H84N16O12 | 112642-11-2 | Details |
| beta-Oxytocin Dimer | C86H132N24O24S4 | 20054-93-7 | Details |
| β-Asp9 Bivalirudin | Details |
| Glu4,Asp5-Oxytocin | Details |
| Oxytocin Open Ring Impurity | Details |
| N-Nitroso Evocalcet | C24H25N3O3 | 3051508-93-8 | Details |
| Octreotide Impurity Y; [Des-Thr-O]8-Des-D-Trp]-OCTR | Details |
| Di-Thr6-Octreotide Octreotide Impurity 18 | Details |
| Glu4,Asp5,Gly9-Oxytocin | Details |
| Pro5-Alarelin | Details |
| (Des-Thr-Ol8)-Octreotide | C45H57N9O9S2 | 160841-00-9 | Details |
| Octreotide impurity D | C45H58N10O8S2 | 79486-60-5 | Details |
| N-Nitroso Meglumine Impurity | C7H16N2O6 | 10356-92-0 | Details |
| 8-D-Arg-Deslorelin | Details |
| L-Lactolactoyl-Phe-Octreotide | Details |
| (D-LEU6,PRO-NHET9)-LHRH(4-9) | C37H62N10O8 | 202333-85-5 | Details |
| Octreotide Impurity 3 Tri-Trifluoroacetate | C36H48N8O8S2 | 191806-77-6 | Details |
| Butyphthalide Impurity 96 | C8H5Br2F3O | 73959-98-5 | Details |
| Cholesterol Impurity 9 | C28H48O | 71075-32-6 | Details |
| Product Total： Product Page： | ||||
| 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 | ||||